Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (10001C_179453 / 1)
Received: 26 April 2019
Accepted: 26 July 2019
First Online: 5 August 2019
Ethics approval and consent to participate
: The study protocol version 2.0 received approval from the “Commission cantonale d’éthique de la recherche CCER” (the ethics committee of the canton of Geneva, Switzerland) on August 7, 2018. The protocol number is 2018–01039.Each participant will provide written informed consent for participation prior to data collection. The eligibility criteria applied in this project should prevent the enrolling of participants demonstrating cognitive difficulties significant enough to seriously jeopardize their capacity for discernment. Should this nevertheless happen, the consent for participation will be gathered from a proxy, ideally the participant’s therapeutic representative.
: Not applicable (the manuscript does not contain any individual person’s data in any form).
: The authors declare that they have no competing interests. Relevant to this statement is a clarification regarding the involvement of imad in the study. Imad is domiciled in Canton Geneva, Switzerland; it is a public autonomous institution that operates under the supervision of the State Council of Canton, Geneva. Cantonal (LIMAD - k1 07, LSDOM - k1 06 and RSDom k1 06.01) and federal laws (LAMal) regulate imad. Its basic financing is predominantly Swiss and public. Projects conducted at imad are non-commercial and of public interest. Also relevant is the fact that the interRAI RAI-HC instrument is used for research purposes, royalty free. Thus, no conflict of interest with the interRAI Consortium exists.